Results 191 to 200 of about 19,899 (215)

Cancer Risks for PMS2-Associated Lynch Syndrome

Journal of Clinical Oncology, 2018
PurposeLynch syndrome due to pathogenic variants in the DNA mismatch repair genes MLH1, MSH2, and MSH6 is predominantly associated with colorectal and endometrial cancer, although extracolonic cancers have been described within the Lynch tumor spectrum.
van Hest, LP, Ten Broeke, Sanne W
openaire   +2 more sources

Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome

Genetics in Medicine, 2022
Michael F Walsh, Ying L. Liu, Kenneth Offit   +2 more
exaly  

Germline PMS2 Mutations: One Hit or Two?

Gastroenterology, 2005
Robert, Gryfe, Steven, Gallinger
openaire   +2 more sources

Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome

Human Mutation, 2016
Sanne W ten Broeke, Wagner Anja, Christi J. van Asperen   +2 more
exaly  

PMS2

2016
openaire   +1 more source

ISOINDOLINES AS PMS2 INHIBITORS

2023
JULIAN BLAGG, DRYSDALE MARTIN, CLARK DAVID, WINSHIP PAUL   +3 more
openaire   +1 more source

Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes†

Human Mutation, 2010
Pinar Bayrak-Toydemir, Rong Mao, Cecily P Vaughn   +2 more
exaly  

PMS2

2006
openaire   +1 more source

PMS2 Deficiency

2019
openaire   +1 more source

Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?

Familial Cancer, 2013
John Potter, Mark Clendenning, Mark Jenkins   +2 more
exaly